The American College of Chest Physicians issued 44 recommendations, covering use of vitamin K antagonists, heparin bridging, direct oral anticoagulants, and antiplatelet drugs in patients undergoing surgeries or procedures.
17 Aug 2022
The latest news on inpatient COVID-19 care includes some changes to the NIH guidelines for COVID-19 treatment, as well as studies showing that rivaroxaban after discharge reduced clots and remdesivir helped inpatients on no or low-flow oxygen but not those who were sicker.
22 Dec 2021
Ninety days after being diagnosed with atrial fibrillation, 51.6% of patients diagnosed in the ED were on oral anticoagulants, compared to 50.9% of those diagnosed in the hospital and 67.9% of those diagnosed as outpatients, a Canadian study found.
3 Aug 2022
The guidance from the American College of Cardiology covers management of major and minor bleeding in patients treated with direct-acting oral anticoagulants or vitamin K antagonists for any indication.
22 Jul 2020
An international registry study compared outcomes in 298 patients who received both prophylactic anticoagulation and aspirin with a propensity-matched group who received anticoagulation alone.
29 Jun 2022
The AREST trial, which ended early due to changes in national guidelines, found statistically similar but numerically lower rates of the primary study outcome (fatal stroke, recurrent ischemic stroke, or transient ischemic attack) in those who received anticoagulation early with apixaban versus later with warfarin.
3 Mar 2021
tPA bolus within 48 hours of DOAC use not associated with increased risk for intracerebral hemorrhage vs. warfarin or no anticoagulation
A systematic review and meta-analysis compared the rate of symptomatic intracerebral hemorrhage in stroke patients pretreated with a direct oral anticoagulant (DOAC) versus those without prior anticoagulation and those on warfarin with an international normalized ratio below 1.7.
8 Jan 2020
Correct coding and sequencing of codes for patients admitted with hypocoagulopathy can be tricky.
18 May 2022
Full-dose anticoagulation appeared to help hospitalized COVID-19 patients who weren't critically ill but not the critically ill, trials showed. Postvaccine myocarditis and pericarditis were investigated by a study, while new data and an FDA authorization supported postexposure prophylaxis for some patients.
11 Aug 2021
A hospitalist explains a recent call for her peers to consider their patients' family planning needs.
6 Jul 2022